SCHEMBL2134050

SCHEMBL2134050

O=C(O)CNC(CO)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.45
MME P08473 5/20 0.39
FOLH1 Q04609 1/20 0.37
RIMKLA Q8IXN7 1/20 0.37
NAALAD2 Q9Y3Q0 1/20 0.37
OR51E2 Q9H255 1/20 0.36
CA2 P00918 2/20 0.33
CA1 P00915 1/20 0.33
MAPT P10636 2/20 0.32
PTGS2 P35354 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KDM4E B2RXH2 1/20 0.32
THRB P10828 1/20 0.32
ALOX15 P16050 1/20 0.32
NFKB1 P19838 1/20 0.32
THPO P40225 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27091944 1.00 TGFBR1 (0.45) TGFBR1MMEFOLH1RIMKLANAALAD2
SCHEMBL1418301 0.98 TGFBR1 (0.43) TGFBR1MMEFOLH1RIMKLANAALAD2
SCHEMBL147537 0.84
SCHEMBL1923394 0.84
SCHEMBL8358625 0.82 FOLH1 (0.43) FOLH1RIMKLANAALAD2MAPTPTGS2
SCHEMBL169227 0.81 FOLH1 (0.39) TGFBR1FOLH1RIMKLANAALAD2
SCHEMBL468808 0.81 TGFBR1 (0.48) TGFBR1MMEFOLH1RIMKLANAALAD2
SCHEMBL3109340 0.81 TGFBR1 (0.52) TGFBR1MMEOR51E2CA2CA1
SCHEMBL29716672 0.81 TGFBR1 (0.42) TGFBR1MMEFOLH1RIMKLANAALAD2
SCHEMBL468807 0.81 TGFBR1 (0.48) TGFBR1MMEFOLH1RIMKLANAALAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570585-B2 Methods and compositions for use in agricultural processes SOLUGEN, INC. (US) 2026-03-10 US claimed
US-20230271892-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES SOLUGEN, INC. (US) 2023-08-31 US claimed
EP-3189116-B1 SLICK-WATER FRACTURING USING TIME RELEASE METAL-COMPLEXING AGENT FLEX CHEM HOLDING COMPANY LLC (US) 2023-08-09 EP claimed
EP-4188074-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES Solugen, Inc. (US) 2023-06-07 EP claimed
WO-2022115283-A1 METHOD FOR IMPROVED OIL RECOVERY IN SUBTERRANEAN FORMATIONS WITH CIRCUMNEUTRAL PH FLOOD HALLIBURTON ENERGY SERVICES, INC. (US) 2022-06-02 WO claimed
US-20220162498-A1 METHOD FOR IMPROVED OIL RECOVERY IN SUBTERRANEAN FORMATIONS WITH CIRCUMNEUTRAL pH FLOOD HALLIBURTON ENERGY SERVICES, INC. 2022-05-26 US claimed
US-11332658-B2 Stimulation of wells in nano-darcy shale formations FLEX-CHEM HOLDING COMPANY, LLC (US) 2022-05-17 US claimed
WO-2022026752-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES SOLUGEN, INC. (US) 2022-02-03 WO claimed
US-11224222-B2 Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions ISP INVESTMENTS LLC (US) 2022-01-18 US claimed
CN-107613954-B Synergistic compositions of dehydroacetic acid and methods of reducing yellowing in various end-use compositions ISP投资有限公司 2021-10-19 CN claimed
WO-2013115981-A1 TREATMENT FLUIDS CONTAINING A BORON TRIFLUORIDE COMPLEX AND METHODS FOR USE THEREOF HALLIBURTON ENERGY SERVICES, INC. (US) 2013-08-08 WO claimed
WO-2012146895-A1 TREATMENT FLUIDS CONTAINING BIODEGRADABLE CHELATING AGENTS AND METHODS FOR USE THEREOF HALLIBURTON ENERGY SERVICES, INC. (US) 2012-11-01 WO claimed
US-20120115759-A1 TREATMENT FLUIDS CONTAINING A BORON TRIFLUORIDE COMPLEX AND METHODS FOR USE THEREOF HALLIBURTON ENERGY SERVICES, INC. (US) 2012-05-10 US claimed
US-20120097392-A1 Treatment Fluids Containing Biodegradable Chelating Agents and Methods for Use Thereof HALLIBURTON ENERGY SERVICES, INC. (US) 2012-04-26 US claimed
CN-1062855-C Process for preparing alkali metal salts of hydroxymethyl-iminodiacetic acid HAMPSHIRE CHEM CORP (US) 2001-03-07 CN claimed
CN-1235974-A Process for preparing phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORP (US) 1999-11-24 CN claimed
EP-0595598-B1 Conversion of hydroxymethyl iminodiacetic acid to phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORP (US) 1997-06-18 EP claimed
CN-1096290-A Conversion of hydroxymethyl-iminodiacetic acid to phosphorylmethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORP (US) 1994-12-14 CN claimed
US-5312972-A Conversion of hydroxymethyl-iminodiacetic acid to phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORP. (US) 1994-05-17 US claimed
EP-0595598-A1 Conversion of hydroxymethyl iminodiacetic acid to phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORPORATION (US) 1994-05-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570585-B2 Methods and compositions for use in agricultural processes SLC5A6, SLC5A2, HK2 TGFBR1 3791/4885MME 4695/4885FOLH1 1284/4885
US-11224222-B2 Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions ALAD, SCD, DHCR7 TGFBR1 4884/4885MME 869/4885FOLH1 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.